Cover Image

Respiratory Disease in the COVID-19 Era

Coronavirus disease 2019 (COVID-19) is a new respiratory disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused a global pandemic. COVID-19 patients often develop acute respiratory distress syndrome (ARDS), which involves acute and lethal respirator...

Full description

Saved in:
Format: Online
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
heart rate
COVID-19
pulmonary rehabilitation
COVID-19 vaccines
adult
pneumonia
risk
SARS-CoV-2
Pneumocystis jirovecii pneumonia
interstitial pneumonia
steroids
immunosuppressive drugs
spontaneous pneumomediastinum
subcutaneous emphysema
therapeutic plasma exchange
ARDS
inflammatory markers
survival
immunocompromised host
Bruton’s tyrosine kinase
persistent infection
pulmonary paragonimiasis
Paragonimus westermani
post-COVID-19 condition
delayed diagnosis
case cluster
Bamlanivimab
Etesevimab
lung ultrasound
RT-qPCR
HRCT
diabetes mellitus
computed tomographic severity score
immunocompromised
coronavirus disease 2019
hydroxychloroquine
severe acute respiratory syndrome
n/a
diaphragm
thoracic mobilization
respiratory function
thema EDItEUR::M Medicine and Nursing
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics
Online Access:ONIX_20230714_9783036579160_58
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

ONIX_20230714_9783036579160_58

Similar Items